XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Details)
 12 Months Ended
Dec. 31, 2022
USD ($)
Commitments and Contingencies (Details) [Line Items]  
Warrant agreement, description The warrant agreement provides that the terms of the warrants may be amended without the consent of any stockholder or warrant holder to cure any ambiguity or correct any defective provision or to make any amendments that are necessary in the good faith determination of the board of directors of the Company (taking into account then existing market precedents) to allow for the warrants to continue to be classified as equity in the Company’s financial statements, but requires the approval by the holders of at least 50% of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants. Accordingly, the Company may amend the terms of the public warrants (i) in a manner adverse to a holder of public warrants if holders of at least 50% of the then outstanding public warrants approve of such amendment or (ii) to the extent necessary for the warrants in the good faith determination of the board of directors of the Company (taking into account then existing market precedents) to allow for the warrants to continue to be classified as equity in the Company’s financial statements without the consent of any stockholder or warrant holder. Although the Company’s ability to amend the terms of the public warrants with the consent of at least 50% of the then outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash or shares, shorten the exercise period or decrease the number of shares of Class A common stock purchasable upon exercise of a warrant. 
Cash underwriting discount 2.00%
Deferred underwriting discount 3.50%
Paid fee in an amount equal percentage 0.30%
Advisory fee percentage 0.525%
Financial advisory fee, description The underwriter has agreed to reimburse the Company for the fee to CCM as it becomes payable out of the underwriting commission. Accordingly, a reimbursement receivable and deferred advisory fee of $1,155,000 has been reflected in the accompanying balance sheets.
Over-Allotment Option [Member]  
Commitments and Contingencies (Details) [Line Items]  
Gross proceeds of public offering (in Dollars) $ 4,973,868
Advisory fee percentage 0.825%
Business Combination [Member]  
Commitments and Contingencies (Details) [Line Items]  
Gross proceeds of public offering (in Dollars) $ 8,704,270